2002
DOI: 10.1590/s0102-86502002000400009
|View full text |Cite
|
Sign up to set email alerts
|

Estudo histológico e computadorizado das áreas com células parietais e principais no estômago de ratos Wistar tratados com pantoprazol e "N-Nitroso-N-Methylurea"(NMU)

Abstract: pantoprazol e "N-Nitroso-N-Methylurea" (NMU). Acta Cir Bras [serial online] 2002 Jul-Ago;17(4). Disponível em URL: http://www.scielo.br/acb. RESUMO -O uso prolongado dos inibidores da bomba de prótons tem sido considerado uma condição de risco para o desenvolvimento de gastrite atrófica e tumores gástricos. Objetivo: Estudar o efeito do uso de pantoprazol (PTZ) e carcinogênese pela "N-Nitroso-N-Methylurea" (NMU), por 15 semanas, sobre o estômago glandular de ratos Wistar, pela análise histológica e computadori… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(7 citation statements)
references
References 12 publications
(16 reference statements)
0
7
0
Order By: Relevance
“…Twelve articles were selected from clinical (9) and experimental (3) studies, for qualitative analysis of the results. Souza et al (2002) studied, for 15 weeks, 40 male Wistar rats divided into four groups: G1 (control), G2 (N-Nitroso-N-Methylurea + pantoprazole ®), G3 (pantoprazole ®) and G4 (N-Nitroso-N-Methylurea). Pantoprazole ® was administered 2x/week (14 mg/ kg body weight, intraperitoneal injection) and NMU offered ad libitum, diluted in drinking water (100 μg/ ml).…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…Twelve articles were selected from clinical (9) and experimental (3) studies, for qualitative analysis of the results. Souza et al (2002) studied, for 15 weeks, 40 male Wistar rats divided into four groups: G1 (control), G2 (N-Nitroso-N-Methylurea + pantoprazole ®), G3 (pantoprazole ®) and G4 (N-Nitroso-N-Methylurea). Pantoprazole ® was administered 2x/week (14 mg/ kg body weight, intraperitoneal injection) and NMU offered ad libitum, diluted in drinking water (100 μg/ ml).…”
Section: Methodsmentioning
confidence: 99%
“…In the Hp negative patients there was no alteration on the oxyntic exocrine mucosa. Chronic gastritis/metaplasia atrophy Souza et al (2002), studying the effects of a prolonged use of pantoprazol®, demonstrated a significant reduction in the area of the oxyntic gastric mucosa (with both main and parietal cells), and significant growth of the non-oxyntic gastric mucosa area in the stomach of Wistar rats. Bardhan et al (2005) showed that chronic gastritis decreased in the pylorus region and increased in the body, which also presented atrophic variations.…”
Section: Clinical Studiesmentioning
confidence: 99%
See 3 more Smart Citations